Business
Holding(s) in Company
Vulpes Investment Management Pte Ltd, through its Vulpes Testudo Fund and Vulpes Life Sciences Fund, has increased its stake in Proteome Sciences PLC, crossing a notification threshold on February 2, 2026. The total voting rights held now stand at 24.22%, representing 84,932,629 shares, up from a previous holding of 22.80%. This acquisition of voting rights is the sole reason for the notification, with no financial instruments involved. Disclaimer*
About this update from Proteome Sciences Plc
TR-1: Standard form for notification of major holdings 1. Issuer Details ISIN GB0003104196 Issuer Name PROTEOME SCIENCES PLC UK or Non-UK Issuer UK 2. Reason for Notification An acquisition or disposal of voting rights 3. Details of person subject to the notification obligation Name Vulpes Investment Management Pte Ltd City of registered office (if applicable) SG Country of registered office (if applicable) Singapore 4. Details of the shareholder Name City of registered office Country of registered office VULPES TESTUDO FUND VULPES LIFE SCIENCES FUND 5. Date on which the threshold was crossed or reached 02-Feb-2026 6. Date on which Issuer notified 04-Feb-2026 7. Total positions of person(s) subject to the notification obligation % of voting rights attached to shares (total of 8.A) % of voting rights through financial instruments (total of 8.B 1 + 8.B 2) Total of both in % (8.A + 8.B) Total number of voting rights held in issuer Resulting situation on the date on which threshold was crossed or reached 24.22 0.00 24.22 84,932,629 Position of previous notification (if applicable) 22.80 0.00 22.80 8. Notified details of the resulting situation on the date on which the threshold was crossed or reached 8A. Voting rights attached to shares Class/Type of shares ISIN code(if possible) Number of direct voting rights (DTR5.1) Number of indirect voting rights (DTR5.2.1) % of direct voting rights (DTR5.1) % of indirect voting rights (DTR5.2.1) GB0003104196 84,932,629 24.22 Sub Total 8.A 84,932,629 24.22% 8B1. Financial Instruments according to (DTR5.3.1R.(1) (a)) Type of financial instrument Expiration date Exercise/conversion period Number of voting rights that may be acquired if the instrument is exercised/converted % of voting rights Sub Total 8.B1 8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b)) Type of financial instrument Expiration date Exercise/conversion period Physical or cash settlement Number of voting rights % of voting rights Sub Total 8.B2 9. Information in relation to the person subject to the notification obligation 1. Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer. Ultimate controlling person Name of controlled undertaking % of v...
View stock analysis, news, and events for Proteome Sciences Plc